BF-158

CNC1=CC=C(C=C1)C2=CC=C3C=CC=CC3=N2

InChIKey=SLVJLLSYTZXMFL-UHFFFAOYSA-N

InChI=1S/C16H14N2/c1-17-14-9-6-13(7-10-14)16-11-8-12-4-2-3-5-15(12)18-16/h2-11,17H,1H3

Stereochemistry	ACHIRAL
Additional Stereochemistry	No
Defined Stereocenters	0 / 0
E/Z Centers	0
Optical Activity	NONE

PubMed

Title	Date	PubMed
Quinoline and benzimidazole derivatives: candidate probes for in vivo imaging of tau pathology in Alzheimer's disease.	2005-11-23	16306398

Patents

Substance Class	Chemical Created by `admin` on `Mon Mar 31 22:50:39 GMT 2025` Edited by `admin` on `Mon Mar 31 22:50:39 GMT 2025`
Record UNII	4K975984MG
Record Status	`Validated (UNII)`
Record Version

Name

Type

Language

BENZENAMINE, N-METHYL-4-(2-QUINOLINYL)-

Preferred Name

English

BF-158

Common Name

English

Code System Code Type Description

CAS

682763-67-3

Created by admin on Mon Mar 31 22:50:39 GMT 2025 , Edited by admin on Mon Mar 31 22:50:39 GMT 2025

PRIMARY

EPA CompTox

DTXSID20218428

Created by admin on Mon Mar 31 22:50:39 GMT 2025 , Edited by admin on Mon Mar 31 22:50:39 GMT 2025

PRIMARY

FDA UNII

4K975984MG

Created by admin on Mon Mar 31 22:50:39 GMT 2025 , Edited by admin on Mon Mar 31 22:50:39 GMT 2025

PRIMARY

PUBCHEM

11776207

Created by admin on Mon Mar 31 22:50:39 GMT 2025 , Edited by admin on Mon Mar 31 22:50:39 GMT 2025

PRIMARY

Related Record Type Details


					4K975984MG

BF-158

ACTIVE MOIETY